High-risk merchant account for hemp-derived CBD brands with a Cyprus company

Our process begins with a detailed review of your business, including your corporate structure, processing history, chargeback ratios and product specifics. We then build a comprehensive underwriting file containing your company's KYB documents, certificates of analysis for your CBD products, website compliance checks and proof of fulfilment. Based on this profile, we identify and engage appropriate EEA-licensed acquirers with an appetite for the specific risks of the CBD industry and experience with Cyprus-based entities. We manage the entire application process, from the initial introduction to handling detailed underwriting questions, ensuring your case is presented clearly and professionally.

Acquirers conduct enhanced due diligence on CBD businesses. Underwriters will scrutinise at least six months of recent processing statements to verify your sales volumes, chargeback rates (typically requiring below 0.75%), and refund levels. They will meticulously review your website for compliance, including ensuring no unauthorised medical claims are made and that product descriptions are accurate. Lab reports (Certificates of Analysis) must be available for all products, proving THC content is within legal limits. Underwriters also require full KYB packs on the Cyprus entity and KYC documentation for all ultimate beneficial owners and directors, verifying their identity and background.

Using a Cyprus company provides a clear European corporate structure, but it comes with specific requirements. Acquirers will expect to see a full set of corporate documents from the Registrar of Companies, including certificates of incorporation, directors, shareholders and the registered office address. While your entity is based in Cyprus, acquiring is often sourced from other EEA jurisdictions. To support this, demonstrating management and control from Cyprus is beneficial. This 'substance' is key not only for local banking but also for satisfying international partners. The primary processing currencies will be EUR and USD, fitting the profile of most international CBD businesses.

Accounts are often declined because the application is incomplete or presented to the wrong type of acquirer. Mainstream providers, for instance, typically refuse CBD sales entirely. We prevent this by targeting only specialist acquirers whose risk appetite aligns with the industry. Closure of an approved account is commonly due to compliance breaches post-onboarding. This includes chargeback ratios exceeding the agreed limits, selling products with THC content above legal thresholds, or making unsubstantiated health claims on your website. Our pre-submission file review and ongoing monitoring guidance helps you avoid these pitfalls, ensuring a stable, long-term processing relationship.

For a well-prepared Cyprus CBD company, the timeline from submitting a complete file to receiving a live merchant account typically ranges from two to six weeks. This includes the acquirer's underwriting and technical integration. Once approved, we assist with configuring your payment gateway, descriptor, and any required reserves. Post-approval, maintaining the account requires diligence. You must consistently monitor chargeback levels, keep product lab certifications current, and notify the acquirer of any significant changes to your business model or ownership. We remain available to help you manage your acquirer relationship and adapt to evolving compliance standards.